Philadelphia’s Storefront Improvement Program Grant

The Fast Track Job Training Assistance Program provides grants to new and expanding companies to support the training of new full-time employees. The amount of funding is based on the number of positions a business creates, the amount of capital it invests, and the compensation it pays its new employees.

The Innovate Alabama Supplemental Grant Program provides additional resources for small businesses whose proven business models and technologies are helping accelerate innovation in the state. Small businesses who have an active Phase I or Phase II Federal Small Business Innovation Research (SBIR) or Small Business Technology Transfer (STTR) grant are eligible for non-dilutive funding from the Innovate Alabama Supplemental Grant Program. This unique grant program provides support for recipients who do not need to exchange shares of their company for the grant. These businesses have proven through scientific review that their technologies are viable, valuable and scalable.

The Additive Voucher Program (AVP) provides companies with a matching grant to assist with the acquisition of Additive Manufacturing technology. Eligible companies can apply for a grant up to $20,000 for Additive Manufacturing Hardware, Software, and related third-party integration services. Funding is awarded on a first-come first-served basis. The program is administered by the Connecticut Center for Advanced Technology with funding provided through the Connecticut Department of Economic and Community Development's Manufacturing Innovation Fund.

Anyone who owns a farmers market in West Virginia can benefit from these grants of $5000. The money can be used towards either infrastructure, such as coolers, display cases, structures, etc., or marketing materials to promote your market. Besides traditional farmers’ markets, the grant is also open to roadside stands, consignment, on-farm stands, mobile markets, and online sellers.

The objective of this funding opportunity is to support investigator-initiated, phase I clinical trials for diagnostic and therapeutic interventions for heart, lung, blood, and sleep (HLBS) disorders in adults and children. The proposed trial can be single or multisite. Applicants applying for funding under this NOFO should be ready to initiate the clinical trial within the first quarter of the project period. Discussion, submission, and attainment of applicable regulatory (FDA, DSMB, IRB) approvals, and establishment of drug (and placebo, if applicable) supplies, and any necessary third-party agreements should be established by the time of award. If time and support for these and other pre-clinical and/or trial readiness activities are desired, applicants should consider the companion NOFO which utilizes an R61/R33 phased approach.